In vitro diagnosis (IVD) is pivotal in modern medicine, enabling early disease detection and
treatment optimization. Omics technologies, particularly proteomics and metabolomics, offer …

In vitro diagnostics (IVD) has played an indispensable role in healthcare system by
providing necessary information to indicate disease condition and guide therapeutic …

Metabolic analysis in biofluids interprets the end products in the bioprocess, emerging as an
irreplaceable disease diagnosis and monitoring platform. Laser desorption/ionization mass …

Nanostructured devices and nanoparticles have fundamentally reshaped the development
of precision healthcare in recent decades. Meanwhile, mass spectrometry (MS)-based …

Enzyme-linked immunosorbent assay (ELISA) is a technique designed for the detection and
quantification of (bio) molecules in a liquid sample. It is a powerful tool in clinical …

Mass spectrometry (MS) based analyses have received intense research interest in a series
of rapidly developing disciplines. Although current MS techniques have enjoyed great …

Liquid biopsy is a new diagnostic concept that provides important information for monitoring
and identifying tumor genomes in body fluid samples. Detection of tumor origin …

The post-genomics era has brought about new Omics biotechnologies, such as proteomics
and metabolomics, as well as their novel applications to personal genomics and the …

For a deep understanding of the human proteome, the first crucial step is always the
effective separation of targeted proteins/peptides from complex samples. In mass …

In vitro diagnosis (IVD) is one vital component of medical tests that detects biological
samples of tissues or bio‐fluids. Recently, mass spectrometry and spectroscopy have been …